73 results
424B5
PCSA
Processa Pharmaceuticals Inc
28 May 24
Prospectus supplement for primary offering
4:49pm
and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy oncology drug products. Our mission is to provide better treatment options … and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy oncology drug products. Our mission is to provide better treatment
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy (“NGC”) oncology drug products. Our mission is to provide better … mission. We continue to be focused on drug products that improve the survival and/or quality of life for patients by improving the safety and/or efficacy
8-K
EX-99.1
u9yahws sjwvr
31 Mar 23
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
8:30am
8-K
EX-99.1
hju63ctombly8ullm95
14 Dec 22
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
11:22am
8-K
EX-99.2
hrhogugp4
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
xulupmkmaqgko44bx
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
7flxfumodacc cnc
4 Nov 22
Other Events
11:24am
8-K
EX-99.1
gibi0eag
12 Aug 22
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
10:35am
8-K
EX-99.1
dmc85 8pblndw3f0
4 Aug 22
Regulation FD Disclosure
9:30am